Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19)
Conditions: Corona Virus Infection; Sars-CoV2 Interventions: Dietary Supplement: Vitamins; Drug: Hydroxychloroquine; Drug: Imatinib; Drug: Favipiravir; Drug: Telmisartan Sponsors: University Hospital, Bordeaux; University of Bordeaux Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials